Company Filing History:
Years Active: 2017
Title: Innovations by Gurunadham Munagala
Introduction
Gurunadham Munagala is a notable inventor based in Jammu, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tubercular agents. With a total of 2 patents, his work focuses on innovative compounds that address critical health challenges.
Latest Patents
Gurunadham Munagala's latest patents include the invention of 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for their preparation. This invention relates to a new generation of triazoles, tetrazoles, isoxazoles, urea, and sulphonamide functionalities. These agents are designed for treating multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), either alone or in combination with other anti-tubercular agents. The new generation of 6-nitro-2,3-dihydronitroimidazooxazoles also demonstrates acceptable pharmacokinetic properties and synergistic effects with known anti-tubercular drugs.
Another significant patent involves substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents. This invention outlines a method for preparing these agents and their application in treating tuberculosis, MDR-TB, and XDR-TB. The general formula for these compounds includes various functional groups that enhance their efficacy against mycobacterial infections.
Career Highlights
Gurunadham Munagala is affiliated with the Council of Scientific & Industrial Research, where he conducts research and development in the pharmaceutical sector. His work has been instrumental in advancing the understanding and treatment of tuberculosis, a disease that poses a significant global health threat.
Collaborations
He collaborates with esteemed colleagues such as Parvinder Pal Singh and Inshad Ali Khan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Gurunadham Munagala's contributions to the field of pharmaceuticals, particularly in the development of anti-tubercular agents, highlight his commitment to addressing critical health issues. His innovative patents reflect a dedication to improving